Besides, in acute myeloid leukemia (AML), TREM2, as a novel receptor for IL-34, can induce myeloid differentiation and inhibit AML progression by inhibiting the ERK1/2/Rasal3 signaling pathway. The gene discussed is IL34; the disease is acute myeloid leukemia.